VintaBio

Biotechnology ResearchPennsylvania, United States11-50 Employees

Biotherapeutics manufacturing partner enabling scalable production while maintaining product quality.

VintaBio is a viral vector development and manufacturing partner supporting biotech and pharmaceutical companies advancing AAV, LVV, adenoviral, Vero-based, vaccine, and other viral vector programs into clinical development.

We specialize in adherent manufacturing across preclinical, IND-enabling, process development, and clinical-stage production.

Our approach enables scalable production, combining biological fidelity with manufacturing efficiency to deliver:

• Higher quality and more consistent product output
• Greater control over production conditions and timing
• Reduced impurity burden and downstream complexity
• Reliable clinical supply and predictable timelines
• Scalable production without increasing manufacturing footprint

We partner with development, CMC, and technical operations teams to reduce scale-up risk, strengthen process control, and accelerate programs toward the clinic — particularly in rare and genetically defined diseases where speed and reliability matter most.

Headquartered in the Philadelphia Navy Yard — a leading hub for cell and gene therapy innovation — VintaBio is focused on delivering scalable, high-quality viral vector manufacturing to support clinical success and long-term therapeutic impact.

To learn more: www.vintabio.com

Sign up for free to view info

Email Format Employee directory